Pulmonary Hypertension

February 24, 2015November 5, 2015

Lung Allocation Score Guidelines For Prioritizing Lung Transplant Allocations Revised

The U.S. Department of Health & Human Services Organ Procurement and Transplantation Network (OPTN) has released modified guidelines to their Lung Allocation Score (LAS) system, effective February 19, 2015. Dr. ... Read more

February 20, 2015November 5, 2015

CTEPH Patients Are More Accurately Assessed During Exercise, Study Shows

News, Pulmonary Hypertension

A team of researchers led Dr. Guido Claessen at the University Hospitals Leuven in Belgium recently published in the journal Heart their findings concerning the evaluation of chronic thromboembolic pulmonary ... Read more

February 16, 2015November 5, 2015

SteadyMed Preps for IPO to Fund PAH Drug Delivery Commercialization

News, Pulmonary Hypertension

SteadyMed Therapeutics, an Israeli based specialty pharmaceutical company that focuses on the development of drug product candidates to treat rare and chronic diseases with unmet parenteral (not delivered via the ... Read more

January 28, 2015November 5, 2015

Children With Pulmonary Hypertension Still a Major Risk Group for Anesthesia Administration

News, Pulmonary Hypertension

A new study entitled “The Impact of Targeted Therapies for Pulmonary Hypertension on Pediatric Intraoperative Morbidity or Mortality” reports that children with pulmonary hypertension are still a risk-group for anesthesia ... Read more

January 27, 2015November 5, 2015

Eleven New PH Care Centers Accredited by the Pulmonary Hypertension Association

News, Pulmonary Hypertension

Eleven new health care centers have received accreditation from the Pulmonary Hypertension Association (PHA) to become recognized Pulmonary Hypertension Care Centers (PHCC). With these additions, there are now 17 PHCCs in the ... Read more

January 20, 2015November 5, 2015

Ascendis Pharma Announces Initiation Of Phase 1 Single Dose Study Of TransCon Treprostinil

News, Pulmonary Hypertension

Ascendis Pharma A/S recently announced that a Phase 1 single ascending dose study of TransCon Treprostinil given to healthy volunteers has been initiated. This trial aims to address therapeutic needs ... Read more

January 16, 2015November 5, 2015

Arena to Initiate Dosing on Phase 2 PAH Therapy Study

News, Pulmonary Hypertension

Arena Pharmaceuticals, Inc. has announced that it will initiate dosing of the first patients in its phase 2 clinical trial for the evaluation of a potential therapy for pulmonary arterial hypertension (PAH), called ralinepag. ... Read more

January 6, 2015November 5, 2015

Suspected Pulmonary Embolism Put Into Better Focus Thanks to New Study

News, Pulmonary Hypertension

A recent study entitled “Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study” reports a similar mortality rate in patients with suspected Pulmonary Embolism, in ... Read more

December 30, 2014November 5, 2015

Actelion Submits New Drug for Pulmonary Arterial Hypertension to FDA

News, Pulmonary Hypertension

Actelion has submitted its new treatment for pulmonary arterial hypertension (PAH) to the U.S. Food and Drug Administration (FDA). The company is applying for a New Drug Application (NDA) for selexipag (Uptravi), after having ... Read more

December 29, 2014November 5, 2015

Medtronic Submits Drug Delivery System to FDA to Complement United Therapeutics’ PAH Treatment

News, Pulmonary Hypertension

Medical technology developer Medtronic, Inc. recently completed an application submission to the U.S. Food and Drug Administration (FDA) regarding the pre-market approval of their SynchroMed II implantable drug infusion system, which includes a new catheter design. The ... Read more